Evaluation of A-331440 analogs with improved safety and efficacy potential as antiobesity histamine H3 receptor (H3R) antagonists

被引:0
|
作者
Hancock, AA [1 ]
Diehl, MS [1 ]
Krishna, G [1 ]
Miller, TR [1 ]
Krueger, KM [1 ]
Pratt, JK [1 ]
Faghih, R [1 ]
Bennani, YL [1 ]
Cowart, MD [1 ]
Esbenshade, T [1 ]
机构
[1] Abbott Labs, Abbott Pk, IL 60064 USA
来源
FASEB JOURNAL | 2004年 / 18卷 / 04期
关键词
D O I
暂无
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
引用
收藏
页码:A574 / A575
页数:2
相关论文
共 50 条
  • [41] Synthesis and SAR of novel histamine H3 receptor antagonists
    Jesudason, Cynthia D.
    Beavers, Lisa S.
    Cramer, Jeffrey W.
    Dill, Joelle
    Finley, Don R.
    Lindsley, Craig W.
    Stevens, F. Craig
    Gadski, Robert A.
    Oldham, Samuel W.
    Pickard, R. Todd
    Siedem, Christopher S.
    Sindelar, Dana K.
    Singh, Ajay
    Watson, Brian M.
    Hipskind, Philip A.
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2006, 16 (13) : 3415 - 3418
  • [42] Molecular modeling of histamine H3 receptor and QSAR studies on arylbenzofuran derived H3 antagonists
    Dastmalchi, Siavoush
    Hamzeh-Mivehroud, Maryam
    Ghafourian, Taravat
    Hamzeiy, Hossain
    JOURNAL OF MOLECULAR GRAPHICS & MODELLING, 2008, 26 (05): : 834 - 844
  • [43] 2. Histaminergic mechanisms in the CNSSelective H3 receptor (H3R) blockade: broad efficacy in cognition and schizophrenia
    G. B. Fox
    T. A. Esbenshade
    J. B. Pan
    K. E. Browman
    M. Zhang
    M. E. Ballard
    R. J. Radek
    H. Miner
    R. S. Bitner
    K. M. Krueger
    B. B. Yao
    R. Faghih
    L. E. Rueter
    V. A. Komater
    K. U. Drescher
    M. J. Buckley
    J. P. Sullivan
    M. D. Cowart
    M. W. Decker
    A. A. Hancock
    Inflammation Research, 2005, 54 : S23 - S24
  • [44] Multiple enzyme inhibitions by histamine H3 receptor antagonists as potential procognitive agents
    Petroianu, G
    Arafat, K
    Sasse, BC
    Stark, H
    PHARMAZIE, 2006, 61 (03): : 179 - 182
  • [45] Synthesis and evaluation of pyridone-phenoxypropyl-R-2-methylpyrrolidine analogues as histamine H3 receptor antagonists
    Becknell, Nadine C.
    Lyons, Jacquelyn A.
    Aimone, Lisa D.
    Gruner, John A.
    Mathiasen, Joanne R.
    Raddatz, Rita
    Hudkins, Robert L.
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2011, 21 (23) : 7076 - 7080
  • [46] Discovery of a New Class of Non-imidazole Oxazoline-Based Histamine H3 Receptor (H3R) Inverse Agonists
    Celanire, Sylvain
    Wijtmans, Maikel
    Christophe, Bernard
    Collart, Philippe
    de Esch, Iwan
    Dassesse, Donald
    Delaunoy, Christel
    Denonne, Frederic
    Durieu, Veronique
    Gelens, Edith
    Gillard, Michel
    Lallemand, Benedicte
    Lamberty, Yves
    Lebon, Florence
    Nicolas, Jean-Marie
    Quere, Luc
    Snip, Erwin
    Vanbellinghen, Alain
    Van Houtvin, Nathalie
    Verbois, Valerie
    Timmerman, Henk
    Talaga, Patrice
    Leurs, Rob
    Provins, Laurent
    CHEMMEDCHEM, 2009, 4 (07) : 1063 - 1068
  • [47] Histamine H3 antagonists in models of obesity
    Hancock, AA
    Bush, EN
    Jacobson, PB
    Faghih, R
    Esbenshade, TA
    INFLAMMATION RESEARCH, 2004, 53 (Suppl 1) : S47 - S48
  • [48] Histamine H3 antagonists in models of obesity
    A. A. Hancock
    E. N. Bush
    P. B. Jacobson
    R. Faghih
    T. A. Esbenshade
    Inflammation Research, 2004, 53 : S47 - S48
  • [49] Differences in pharmacological properties of histamine H3 receptor agonists and antagonists revealed at two human H3 receptor isoforms
    T. A. Esbenshade
    K. M. Krueger
    B. B. Yao
    D. G. Witte
    B. R. Estvander
    J. L. Baranowski
    T. R. Miller
    A. A. Hancock
    Inflammation Research, 2006, 55 : S45 - S46
  • [50] Substituted N-phenylcarbamates as histamine H3 receptor antagonists with improved in vivo potency
    Reidemeister, S
    Stark, H
    Ligneau, X
    Ganellin, CR
    Schwartz, JC
    Schunack, W
    PHARMAZIE, 2000, 55 (02): : 83 - 86